Report error Found 7 Enz. Inhib. hit(s) with all data for entry = 12532
Affinity DataIC50: 51nMAssay Description:Asymmetric bis-benzimidazole compounds (BBI) of the invention were assessed in a biochemical homogeneous time resolved fluorescence (HTRF) binding as...More data for this Ligand-Target Pair
Affinity DataIC50: 57nMAssay Description:Asymmetric bis-benzimidazole compounds (BBI) of the invention were assessed in a biochemical homogeneous time resolved fluorescence (HTRF) binding as...More data for this Ligand-Target Pair
Affinity DataIC50: 73nMAssay Description:Asymmetric bis-benzimidazole compounds (BBI) of the invention were assessed in a biochemical homogeneous time resolved fluorescence (HTRF) binding as...More data for this Ligand-Target Pair
Affinity DataIC50: 150nMAssay Description:Asymmetric bis-benzimidazole compounds (BBI) of the invention were assessed in a biochemical homogeneous time resolved fluorescence (HTRF) binding as...More data for this Ligand-Target Pair
Affinity DataIC50: 210nMAssay Description:Asymmetric bis-benzimidazole compounds (BBI) of the invention were assessed in a biochemical homogeneous time resolved fluorescence (HTRF) binding as...More data for this Ligand-Target Pair
Affinity DataIC50: 250nMAssay Description:Asymmetric bis-benzimidazole compounds (BBI) of the invention were assessed in a biochemical homogeneous time resolved fluorescence (HTRF) binding as...More data for this Ligand-Target Pair
Affinity DataIC50: 440nMAssay Description:Asymmetric bis-benzimidazole compounds (BBI) of the invention were assessed in a biochemical homogeneous time resolved fluorescence (HTRF) binding as...More data for this Ligand-Target Pair
